DEANGELO COOPER: Open Payments
NPI 1528526704 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,367 in 63 payments from 12 companies in 2025. Trend: 2023 $2,295 · 2024 $1,860 · 2025 $1,367
Food & beverage: $1,256Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $302 |
| Teva Pharmaceuticals USA, Inc. | 8 | $238 |
| ABBVIE INC. | 18 | $205 |
| Vanda Pharmaceuticals Inc. | 3 | $115 |
| Neurocrine BioSciences, Inc. | 3 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| Axsome Therapeutics, Inc. | 3 | $86 |
| Lundbeck LLC | 3 | $83 |
| Janssen Pharmaceuticals, Inc | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $53 |
Products named: REXULTI, VRAYLAR, ABILIFY MAINTENA, FANAPT, INGREZZA, TRINTELLIX, Auvelity, UZEDY.
Industry payments across AL — which companies pay providers there.
